美股周一早盘,生物制药企业Summit Therapeutics(SMMT)股价下跌4.9%,此前该公司报告第三季度每股亏损0.13美元,未达预期。尽管盈利不及预期,公司现金储备依然雄厚,支持其持续的战略计划。

本文地址: http://www.jiaotongmi.com/article/22262.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-10admin
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-11-03admin
2025-10-29admin
2025-10-29admin
2025-09-08admin
2025-09-13admin
2025-09-08admin
2025-09-17admin
2025-09-08admin
2025-09-17admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
扫码二维码
获取最新动态
